Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer’s disease

BACKGROUND: Muramyl dipeptide (MDP) is a component derived from minimal peptidoglycan motif from bacteria, and it is a ligand for the NOD2 receptor. Peripheral administration of MDP converts Ly6C(high) into Ly6C(low) monocytes. Previously, we have shown that Ly6C(low) monocytes play crucial roles in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fani Maleki, Adham, Cisbani, Giulia, Plante, Marie-Michèle, Préfontaine, Paul, Laflamme, Nataly, Gosselin, Jean, Rivest, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376735/
https://www.ncbi.nlm.nih.gov/pubmed/32698829
http://dx.doi.org/10.1186/s12974-020-01893-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376735/
https://www.ncbi.nlm.nih.gov/pubmed/32698829
http://dx.doi.org/10.1186/s12974-020-01893-3

Ejemplares similares